-
公开(公告)号：US20230346711A1
公开(公告)日：2023-11-02
申请号：US18220852
申请日：2023-07-12
申请人： Arkema Inc.
CPC分类号： A61K9/5089 , A61K31/327 , A61K8/11 , A61K8/38 , A61Q19/00 , A61K9/0014 , A61K9/06 , A61K9/4858 , A61K2800/412 , A61Q17/04
摘要： Encapsulated peroxide particles inhibit skin inflammation. A method of encapsulating a solid peroxide comprises dispersing solid peroxide particles (e.g., benzoyl peroxide) in an aqueous dispersion of fatty acid salt to form a peroxide/fatty acid salt dispersion, wherein the peroxide particles have a mean particle size (D50) of 10 μm or less; and subsequently encapsulating the solid peroxide particles by reacting the one or more monovalent fatty acid salts with one or more multivalent salts of calcium, magnesium, aluminum, silver, and/or zinc, thereby forming encapsulated peroxide particles.
-
公开(公告)号：US20230329235A1
公开(公告)日：2023-10-19
申请号：US18317768
申请日：2023-05-15
申请人： ECOLAB USA INC.
发明人： Junzhong Li , Allison Brewster , Richard Staub , Steven J. Lange , Taz Cheritu , Jonathan P. Fast , Catherine Hanson
IPC分类号： A01N37/16 , C07C407/00 , C11D3/00 , C12P7/40 , C11D3/39 , C11D3/48 , C07C409/24 , A01N37/00 , A61L2/00 , A61L2/16 , A61K8/38 , A61Q17/00
CPC分类号： A01N37/16 , C07C407/00 , C11D3/00 , C12P7/40 , C11D3/3947 , C11D3/48 , C07C409/24 , A01N37/00 , A61L2/00 , A61L2/16 , A61K8/38 , A61Q17/005
摘要： The present invention relates generally to peroxyformic acid forming compositions, methods for forming peroxyformic acid, preferably in situ, using the peroxyformic acid forming compositions. The present invention also relates to the peroxyformic acid formed by the above compositions and methods. The present invention further relates to the uses of the peroxyformic acid, preferably in situ, for treating a surface or a target. The present invention further relates to methods for treating a biofilm using peroxyformic acid, including peroxyformic acid generated in situ.
-
公开(公告)号：US11730688B2
公开(公告)日：2023-08-22
申请号：US16062282
申请日：2016-12-20
申请人： L'OREAL
发明人： Valérie Nicou , Aziz Fadli , Frédéric Le Grand
CPC分类号： A61K8/494 , A61K8/38 , A61K8/415 , A61K8/416 , A61Q5/10 , A61K2800/42 , A61K2800/4324 , A61K2800/88
摘要： Composition for dyeing the hair, comprising a heterocyclic oxidation base and a 2-amino-5-ethylphenol coupler The present invention relates to a composition for dyeing keratin fibres, comprising a particular heterocyclic oxidation base and a 2-amino-5-ethylphenol coupler. The invention also relates to a process for dyeing keratin fibres using this composition. Finally, the invention relates to the use of such a composition for dyeing keratin fibres, and in particular the hair.
-
公开(公告)号：US09974624B2
公开(公告)日：2018-05-22
申请号：US15427473
申请日：2017-02-08
IPC分类号： A61K8/43 , A61B50/30 , B65D5/42 , B65D5/54 , B65D5/72 , B65D75/58 , B65D75/32 , B65D77/04 , G09B19/00 , A61Q11/00 , A61K8/66 , A61K8/22
CPC分类号： A61B50/30 , A61B2050/3005 , A61J1/00 , A61J1/035 , A61J7/0076 , A61J7/0084 , A61J7/04 , A61K8/22 , A61K8/365 , A61K8/38 , A61K8/43 , A61K8/66 , A61K2800/88 , A61K2800/884 , A61Q11/00 , B65D5/4212 , B65D5/5445 , B65D5/724 , B65D5/725 , B65D75/32 , B65D75/5855 , B65D77/0413 , B65D83/00 , G09B19/00
摘要： A prophylactic kit apparatus configured to be used with only a single patient includes a plurality of sealed modules and a housing configured to contain those sealed modules such that only one of the plurality of sealed modules can be removed from the housing at a time. This kit may include a physically-discrete informational patient aid disposed within the housing and having information disposed thereon. By one approach these physically-discrete informational patient aids can have a bookmark form factor. So configured, a medical services provider can readily provide the physically-discrete informational patient aid to a patient to thereby facilitate the patient becoming informed regarding the corresponding prophylactic service with little or no burden on the service provider.
-
公开(公告)号：US20180117369A1
公开(公告)日：2018-05-03
申请号：US15834805
申请日：2017-12-07
IPC分类号： A61Q19/00 , B01J13/14 , A61K9/51 , A61K8/11 , A61K8/67 , A61K8/38 , A61K8/26 , A61K8/25 , A61K9/00
CPC分类号： A61Q19/00 , A61K8/11 , A61K8/25 , A61K8/26 , A61K8/38 , A61K8/671 , A61K9/0014 , A61K9/5115 , A61K9/5192 , A61K2800/412 , B01J13/14
摘要： The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within a metal oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
-
公开(公告)号：US20170216158A1
公开(公告)日：2017-08-03
申请号：US15490923
申请日：2017-04-19
IPC分类号： A61K8/04 , A61K8/21 , A61K8/34 , A61K8/46 , A61K8/24 , A61K8/55 , A61K8/25 , A61K8/49 , A61K8/29 , A61K8/44 , A61K8/73 , A61Q11/00 , A61K8/19
CPC分类号： A61K8/042 , A61K8/046 , A61K8/19 , A61K8/21 , A61K8/22 , A61K8/24 , A61K8/25 , A61K8/29 , A61K8/342 , A61K8/345 , A61K8/38 , A61K8/44 , A61K8/442 , A61K8/463 , A61K8/466 , A61K8/49 , A61K8/4926 , A61K8/553 , A61K8/69 , A61K8/73 , A61K8/731 , A61K2800/28 , A61K2800/48 , A61K2800/59 , A61K2800/592 , A61K2800/5922 , A61K2800/92 , A61Q11/00
摘要： The present invention is directed to an oral composition containing a gel network phase comprising: (i) one or more fatty amphiphiles, (ii) one or more surfactants, and (iii) one or more solvents; and an oral carrier phase. In certain embodiments, the gel network is used to structure the oral composition. The present invention is also directed to a method of forming an oral composition containing a gel network.
-
公开(公告)号：US20170157034A1
公开(公告)日：2017-06-08
申请号：US15442140
申请日：2017-02-24
申请人： Andrew M. Klapper
发明人： Andrew M. Klapper
IPC分类号： A61K8/99 , A61K8/34 , A61K8/36 , A61K8/97 , A61K8/02 , A61K8/26 , A61K8/73 , A61K8/35 , A61Q19/08 , A61K8/38 , A61K8/25
CPC分类号： A61K35/741 , A61K8/0229 , A61K8/25 , A61K8/26 , A61K8/342 , A61K8/345 , A61K8/35 , A61K8/361 , A61K8/38 , A61K8/73 , A61K8/97 , A61K8/99 , A61K35/747 , A61K45/06 , A61K2800/31 , A61Q19/00 , A61Q19/08
摘要： The invention relates to an anhydrous mixture of biologically active probiotic bacteria for topical administration and methods of making thereof. The mixture of the invention is used for hydrating the skin, reducing and preventing fine lines and wrinkles, treating acne and decreasing skin inflammation.
-
公开(公告)号：US20170143439A1
公开(公告)日：2017-05-25
申请号：US15427473
申请日：2017-02-08
IPC分类号： A61B50/30 , B65D5/54 , B65D5/72 , B65D75/58 , A61K8/22 , B65D77/04 , G09B19/00 , A61Q11/00 , A61K8/43 , A61K8/66 , B65D5/42 , B65D75/32
CPC分类号： A61B50/30 , A61B2050/3005 , A61J1/00 , A61J1/035 , A61J7/0076 , A61J7/0084 , A61J7/04 , A61K8/22 , A61K8/365 , A61K8/38 , A61K8/43 , A61K8/66 , A61K2800/88 , A61K2800/884 , A61Q11/00 , B65D5/4212 , B65D5/5445 , B65D5/724 , B65D5/725 , B65D75/32 , B65D75/5855 , B65D77/0413 , B65D83/00 , G09B19/00
摘要： A prophylactic kit apparatus configured to be used with only a single patient includes a plurality of sealed modules and a housing configured to contain those sealed modules such that only one of the plurality of sealed modules can be removed from the housing at a time. This kit may include a physically-discrete informational patient aid disposed within the housing and having information disposed thereon. By one approach these physically-discrete informational patient aids can have a bookmark form factor. So configured, a medical services provider can readily provide the physically-discrete informational patient aid to a patient to thereby facilitate the patient becoming informed regarding the corresponding prophylactic service with little or no burden on the service provider.
-
公开(公告)号：US09603929B2
公开(公告)日：2017-03-28
申请号：US14539310
申请日：2014-11-12
IPC分类号： A61K33/40 , A61K41/00 , A61K31/4166 , A61K31/7008 , A61K31/728 , A61K45/06 , A61K31/327 , A61K8/38 , A61K8/49 , A61K8/60 , A61K8/73 , A61K8/97 , A61N5/06 , A61Q11/00 , A61Q17/00
CPC分类号： A61K41/0057 , A61K8/38 , A61K8/494 , A61K8/498 , A61K8/602 , A61K8/735 , A61K8/97 , A61K9/006 , A61K31/327 , A61K31/4166 , A61K31/7008 , A61K31/728 , A61K33/40 , A61K41/0038 , A61K41/0042 , A61K41/008 , A61K45/06 , A61N5/0603 , A61N5/062 , A61N5/0624 , A61N2005/0606 , A61N2005/0652 , A61N2005/0663 , A61Q11/00 , A61Q17/005 , A61K2300/00
摘要： The present document describes methods of use of photo activated compositions for oral disinfection and/or treatments which comprise at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmacologically acceptable carrier.
-
公开(公告)号：US20160263011A1
公开(公告)日：2016-09-15
申请号：US15031758
申请日：2014-10-21
申请人： L'OREAL
发明人： Joan EILSTEIN , Corinne FERRARIS
IPC分类号： A61K8/92 , A61K8/38 , A61K8/31 , A61Q19/08 , A61K8/34 , A61K8/37 , A61K8/02 , A61K8/35 , A61K8/49
CPC分类号： A61K8/922 , A61K8/0216 , A61K8/31 , A61K8/34 , A61K8/35 , A61K8/37 , A61K8/38 , A61K8/498 , A61K2236/37 , A61K2800/596 , A61K2800/70 , A61Q19/08
摘要： The present invention relates to the cosmetic use of an essential oil of Achillea, as an active agent for preventing and/or treating the signs of skin ageing, characterized in that this essential oil of Achillea comprises the following compounds, each present at more than 5% by weight relative to the total weight of the essential oil: artemisia ketone, chrysanthenone (two combined isomers), and ascaridole. It also relates to the associated cosmetic process.
摘要翻译： 本发明涉及Achillea精油的美容用途，作为预防和/或治疗皮肤老化症状的活性剂，其特征在于这种Achillea精油包含以下化合物，各自存在于5以上 重量百分比相对于精油：蒿酮，菊苣酮（两种组合异构体）和蛔虫油的总重量。 它还涉及相关的美容方法。
-
-
-
-
-
-
-
-
-
搜索结果
540 条记录 (耗时 0.027 秒)
